SCHEMBL5164933

SCHEMBL5164933

Cc1cnc(NC(=O)Nc2cc(C#C[Si](C)(C)C)ccc2OCc2cccnc2)cn1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 10/20 0.49
KDM4E B2RXH2 4/20 0.42
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
POLB P06746 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
LRRK2 Q5S007 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CHEK2 O96017 1/20 0.38
AKT1 P31749 1/20 0.38
ACACB O00763 1/20 0.38
IRAK4 Q9NWZ3 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
TSHR P16473 1/20 0.38
HSD17B10 Q99714 1/20 0.38
FECH P22830 1/20 0.37
KCNH2 Q12809 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5163913 0.89 CHEK1 (0.51) CHEK1KDM4EKMT2AMEN1POLB
SCHEMBL2034828 0.85 KDM4E (0.55) CHEK1KDM4EKMT2AMEN1POLB
SCHEMBL2037216 0.84 CHEK1 (0.51) CHEK1KDM4EKMT2AMEN1LRRK2
SCHEMBL2035058 0.81 LRRK2 (0.51) CHEK1LRRK2CHEK2IRAK4
SCHEMBL5163651 0.80 CHEK1 (0.47) CHEK1KDM4ECHEK2AKT1FECH
SCHEMBL5163297 0.80 CHEK1 (0.51) CHEK1KDM4EKMT2AMEN1LRRK2
SCHEMBL2035648 0.78 CHEK1 (0.54) CHEK1KDM4EKMT2AMEN1LRRK2
SCHEMBL2035402 0.78 CHEK1 (0.51) CHEK1KDM4EKMT2AMEN1LRRK2
SCHEMBL2035693 0.77 BRD4 (0.53) CHEK1KDM4EKMT2AMEN1POLB
SCHEMBL2035559 0.77 CHEK1 (0.51) CHEK1KDM4EKMT2AMEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1765808-A1 BISARYLUREA DERIVATIVES USEFUL FOR INHIBITING CHK1 ICOS Corporation (US) 2007-03-28 EP disclosed
WO-2006012308-A1 BISARYLUREA DERIVATIVES USEFUL FOR INHIBITING CHK1 ICOS CORPORATION (US) 2006-02-02 WO disclosed